126 related articles for article (PubMed ID: 3146171)
1. Immune response in cystic fibrosis to outer membrane proteins of Pseudomonas aeruginosa.
Kubesch P; von Specht BU; Tümmler B
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):395-410. PubMed ID: 3146171
[TBL] [Abstract][Full Text] [Related]
2. Serum antibodies to Pseudomonas aeruginosa outer-membrane proteins and iron-regulated membrane proteins at different stages of chronic cystic fibrosis lung infection.
Shand GH; Pedersen SS; Brown MR; Høiby N
J Med Microbiol; 1991 Apr; 34(4):203-12. PubMed ID: 1902261
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to Pseudomonas aeruginosa surface protein antigens in a rat model of chronic lung infection.
Cochrane DM; Brown MR; Anwar H; Weller PH; Lam K; Costerton JW
J Med Microbiol; 1988 Dec; 27(4):255-61. PubMed ID: 3143837
[TBL] [Abstract][Full Text] [Related]
4. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa.
Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR
FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670
[TBL] [Abstract][Full Text] [Related]
5. Role of IgG subclass response to outer-membrane proteins in inhibiting adhesion of Pseudomonas aeruginosa to epithelial cells.
Morrin M; Reen DJ
J Med Microbiol; 1993 Dec; 39(6):467-72. PubMed ID: 8246267
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to outer-membrane antigens of Pseudomonas aeruginosa in human burn wound infection.
Ward KH; Anwar H; Brown RW; Wale J; Gowar J
J Med Microbiol; 1988 Nov; 27(3):179-90. PubMed ID: 3143013
[TBL] [Abstract][Full Text] [Related]
7. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis.
Hancock RE; Mouat EC; Speert DP
J Infect Dis; 1984 Feb; 149(2):220-6. PubMed ID: 6421943
[TBL] [Abstract][Full Text] [Related]
8. Serum IgG antibody to outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis.
Aronoff SC; Stern RC
J Infect Dis; 1988 May; 157(5):934-40. PubMed ID: 2452219
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis.
Aronoff SC; Quinn FJ; Stern RC
Pediatr Pulmonol; 1991; 11(4):289-93. PubMed ID: 1722035
[TBL] [Abstract][Full Text] [Related]
10. Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis.
Weisner AM; Chart H; Bush A; Davies JC; Pitt TL
J Med Microbiol; 2007 May; 56(Pt 5):670-674. PubMed ID: 17446292
[TBL] [Abstract][Full Text] [Related]
11. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection.
Giordano A; Magni A; Filadoro F; Graziani C; Quattrucci S; Cipriani P
New Microbiol; 1998 Oct; 21(4):375-8. PubMed ID: 9812319
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of monoclonal antibodies to outer membrane proteins of Pseudomonas aeruginosa grown in iron-depleted media.
Smith AW; Wilton J; Clark SA; Alpar O; Melling J; Brown MR
J Gen Microbiol; 1991 Feb; 137(2):227-36. PubMed ID: 1901901
[TBL] [Abstract][Full Text] [Related]
13. Determination of IgG subclass antibodies to Pseudomonas aeruginosa outer membrane proteins in cystic fibrosis lung infection using immunoblotting and enzyme-linked immunosorbent assay.
Pressler T; Kronborg G; Shand GH; Mansa B; Høiby N
Med Microbiol Immunol; 1992; 181(6):339-49. PubMed ID: 1287420
[TBL] [Abstract][Full Text] [Related]
14. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
15. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E
Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic potential of monoclonal antibodies against Pseudomonas aeruginosa protein F.
Hancock RE; Mutharia LM; Mouat EC
Eur J Clin Microbiol; 1985 Apr; 4(2):224-7. PubMed ID: 2408887
[TBL] [Abstract][Full Text] [Related]
17. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung.
Kubesch P; Lingner M; Grothues D; Wehsling M; Tümmler B
Scand J Gastroenterol Suppl; 1988; 143():77-80. PubMed ID: 3133755
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G; Shand GH; Fomsgaard A; Høiby N
APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
[TBL] [Abstract][Full Text] [Related]
19. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
Bruderer U; Cryz SJ; Schaad UB; Deusinger M; Que JU; Lang AB
J Infect Dis; 1992 Aug; 166(2):344-9. PubMed ID: 1634805
[TBL] [Abstract][Full Text] [Related]
20. Use of immunoblot detection of serum antibodies in the diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Shand GH; Pedersen SS; Tilling R; Brown MR; Høiby N
J Med Microbiol; 1988 Nov; 27(3):169-77. PubMed ID: 3143012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
